Deep Longevity is a Hong Kong-based AI-powered deep biomarker platform that offers biological age prediction solutions for health clubs and insurance companies. Deep Longevity was founded in 2020. Deep Longevity's headquarters is located in Hong Kong,... Deep Longevity's CEO, Deepankar Nayak, currently has an approval
rating of 90%. Deep Longevity's primary competitors are HautAI, Sharecare & Gero .
There have been no acquisitions found related to Deep Longevity
Recent investment data cannot be found related to Deep Longevity